未登录.png)
分享.png)
收藏Effectiveness, pharmacokinetics, and safety of triptorelin acetate microspheres in patients with locally advanced and metastatic prostate cancer
Wu, Guolan; Zhou, Feng; Wang, Haiping; Liu, Kan; Yu, Dexin; Fan, Lianlian; Han, Yangyun; Ai, Xiaohong; Cao, Youhan; Wang, Xiaolin; Wang, Sheng; He, Chaohong; Wu, Jitao; Wu, Ji; Wang, Youlei; Wang, Yanqing; Jin, Baiye; Shentu, Jianzhong 分享 收藏 Association between deep prostate-specific antigen decline and survival in patients with high-volume metastatic hormone-sensitive prostate cancer treated with rezvilutamide in the CHART trialChang, K.; Zhang, X.; Xie, L.; Wang, S.; Shi, B.; Sun, T.; Wei, S.; Weng, Z.; Xia, S.; Han, B.; Xu, Z.; Xing, J.; Zhang, D.; Xu, D.; Du, C.; He, C.; Wang, Q.; Lian, J.; Shi, Q.; Ye, D. 分享 收藏 RENOTORCH: Toripalimab combined with axitinib versus sunitinib in first-line treatment of advanced renal-cell carcinoma (RCC) - A randomized, open-label, phase III studySheng, X.; Ye, M.; Zou, Q.; Chen, P.; He, Z.; Wu, B.; He, D.; He, C.; Xue, X.; Ji, Z.; Chen, H.; Zhang, S.; Liu, Y.; Zhai, W.; Zhang, X.; Fu, C.; Xu, D.; Qiu, M.; Huang, Y.; Guo, J. 分享 收藏 Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)Sheng, Xinan; Ye, DingWei; Zhou, Aiping; Yao, Xin; Luo, Hong; He, Zhisong; Wang, Zengjun; Zhao, Yingchao; Ji, Zhigang; Zou, Qing; He, Chaohong; Guo, Jianming; Tu, Xinhua; Liu, Ziling; Shi, Benkang; Liu, Ben; Chen, Peng; Wei, Qiang; Hu, Zhiquan; Zhang, Yanqiao; Jiang, Kui; Zhou, Fangjian; Wu, Dapeng; Fu, Cheng; Li, Xingya; Wu, Bin; Wang, Lijie; Qin, Shukui; Li, Gang; Liu, Yunpeng; Guo, Hongqian; Chen, Kehe; Zhang, Dahong; Wang, Gongxian; Ding, Lieming; Wang, Yang; Yuan, Xiaobin; Guo, Jun 分享 收藏 Camrelizumab plus famitinib for advanced or metastatic urothelial carcinoma after platinum-based therapy: data from a multicohort phase 2 studyQu, Yuan-Yuan; Sun, Zhongquan; Han, Weiqing; Zou, Qing; Xing, Nianzeng; Luo, Hong; Zhang, Xuepei; He, Chaohong; Bian, Xiao-Jie; Cai, Jinling; Chen, Chunxia; Wang, Quanren; Ye, Ding-Wei 分享 收藏 Activity and safety of SHR3680, a novel antiandrogen, in patients with metastatic castration-resistant prostate cancer: a phase I/II trialQin, Xiaojian; Ji, Dongmei; Gu, Weijie; Han, Weiqing; Luo, Hong; Du, Chuanjun; Zou, Qing; Sun, Zhongquan; He, Chaohong; Zhu, Shaoxing; Chong, Tie; Yao, Xin; Wan, Ben; Yang, Xinfeng; Bai, Aobing; Jin, Chunlei; Zou, Jianjun; Ye, Dingwei 分享 收藏 分享 收藏 Camrelizumab plus Famitinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: Data from an Open-label, Multicenter Phase II Basket StudyQu, Yuan-Yuan; Zhang, Hai-Liang; Guo, Hongqian; Luo, Hong; Zou, Qing; Xing, Nianzeng; Xia, Shujie; Sun, Zhongquan; Zhang, Xuepei; He, Chaohong; Cai, Jinling; Zhang, Xiao; Wang, Quanren; Ye, Ding-Wei 分享 收藏 A multi-institutional retrospective study of hyperthermic plus intravesical chemotherapy versus intravesical chemotherapy treatment alone in intermediate and high risk nonmuscle-invasive bladder cancerRuan, Qiang; Ding, Degang; Wang, Bin; He, Chaohong; Ren, Xuequn; Feng, Zhenhua; Pang, Zhigang; Wang, Jin; Zhang, Xiangliang; Tang, Hongsheng; Wang, Jiahong; He, Qingjun; Lei, Ziying; Liao, Quanxing; Luo, Jiali; Cui, Shuzhong 分享 收藏 分享 收藏 Combining Protein and miRNA Quantification for Bladder Cancer Analysis结合蛋白质和miRNA定量分析膀胱癌Duan, Ruixue; Zhang, Zhenyu; Zheng, Fuxin; Wang, Longwang; Guo, Ju; Zhang, Tianchi; Dai, Xiaomeng; Zhang, Shengwei; Yang, Dong; Kuang, Renrui; Wang, Gongxian; He, Chaohong; Hakeem, Abdul; Shu, Chang; Yin, Ping; Lou, Xiaoding; Zeng, Fuqing; Liang, Huageng; Xia, Fan 分享 收藏 With or without Consolidation Chemotherapy for Clinical Responder to Definitive Concurrent Chemoradiation in Stage II-III Esophageal Squamous Cell CarcinomaChen, Y.; Cheng, X.; Liu, Y.; Zhang, Y.; Wu, X.; Hao, D.; He, C.; Wang, W.; Jiang, Q.; Liu, J.; Wang, J. 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
